Tascatx
Boston, US · 1 known investors
Find your way into Tascatx
21 people in our graph share verified history with the Tascatx team — schools, employers, funds. One of them is your warm intro.
Bill Amsbaughunlockedknows Dr. Milenko Cicmil · together at Cure Ventures
×11knows the team · via Cure Ventures
Tasca Therapeutics develops novel cancer therapies using mass spectrometry-based proteomics to identify cancer-causing proteins with auto-palmitoylation modifications, targeting previously unknown binding pockets for difficult-to-treat cancers. The company's lead program, CP-383, is in preclinical development with expected clinical trial entry in 2025.
Founders & leadership
DM
DD
Dr. David FisherCo-founder
DX
Dr. Xu WuCo-founder
DP
Duojia PanCo-founder
Investors · 1
Frequently asked questions
- What does Tascatx do?
- Tasca Therapeutics develops novel cancer therapies using mass spectrometry-based proteomics to identify cancer-causing proteins with auto-palmitoylation modifications, targeting previously unknown binding pockets for difficult-to-treat cancers. The company's lead program, CP-383, is in preclinical development with expected clinical trial entry in 2025.
- Who founded Tascatx?
- Tascatx was founded by Dr. Milenko Cicmil, Dr. David Fisher, Dr. Xu Wu, Duojia Pan.
- Who are Tascatx's investors?
- Tascatx's investors include Cure Ventures.
- Where is Tascatx headquartered?
- Tascatx is headquartered in Boston, US.